{"ticker": {"uuid": "1fd8285a-521c-4704-8a16-0cb6f4e59c1f", "symbol": "NOVO-B", "name": "Novo Nordisk A/S", "exchange": "CPH", "country": "DK", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Novo Nordisk stock trades near record levels as obesity and diabetes momentum supports earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOdXFiNllNOG5XUC1MNVZmUXhuSGZINHo1U0dWeUhXQU5Cay16LUZ3aWEtRUV3SUpnaFZuR0VoREpleGpHVEJyT2pWWFZvZEg2N1hJLWNGWkFoazR3cUVsclo0anVuTHJhdU9nRnpkRy1lbVlGOC04dlFxWXRBVVh4dnJKVEhsZ0s0djBRMzRCSGlKZm50UGE4STFwT2hwLWpObFRwTWlVSVN3NTN5Ymg5YW9obzd3V29XbWVMbkhJYjhLMnNIcmc?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-18T05:55:14+00:00", "published_display": "18 Jul 2026 05:55", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: EU Approval of Wegovy Pill Expands Opportunity, but Cash Pay Raises Systematic Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQaDNxLTU4ZE54al81a19uZ2p1MnBnb2JkU1VuQnotRnFRNGo0WTYxVnJyTGQ0b09zbWpIck85dUZSX0NncnRYVmMtdjE0R0N2QWg5c3RrYWVKWkQ2cTVwU1VLVTBLLVZTQXF3Tkh4YlYxSHNpZkRRMjZ2dlpndVpHaldfSjlrUEFTX0hqdE1HZUhKRzZSVzN6aGRLX1phV1RpbHpOWkoxT0d3ejlBUmdyS29TY3VmWjBVanBNREZPcTQ?oc=5", "source_name": "Morningstar", "published_at": "2026-07-17T17:59:32+00:00", "published_display": "17 Jul 2026 17:59", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: The Oral Wegovy Promise (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQb01MdlVpaEx4MkJMVDBLd3VLZUFiNjJYeGN2SEgyY3cxWXBvajhpQS1lVXdEYlplV3ZIWllOa2RrZjczdEx3VVlRNXdrZU1yOEpMMUdTa2pUaThhc1ZJc2loT3hNZXZoYThfdXFiM3V5Y0RtcUhMay1YMHBlOTFyM1ZxUQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-17T15:12:03+00:00", "published_display": "17 Jul 2026 15:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NVO) Ascends While Market Falls: Some Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSjJYdTRoRXFoZ1FMUjNQMTZuNHdZNHBWcGxheEtzMjVwbnRCbHJoQ1VrR3poU0JpcWVuNkRDVm9vMVZIZF9LenowZ1R0bHpuOVphZlBDOFpzT3Ixa1MyMmNTaWV5azRzVWZZS2kyS1ppbHRHMFhuOUlmaWctSzJveWlkVkRKbWdXY1dBc0Q3Nm0xUWJxSmhSU01BYw?oc=5", "source_name": "Market source", "published_at": "2026-07-16T21:45:02+00:00", "published_display": "16 Jul 2026 21:45", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Stock Up Over 2% Premarket Today \u2014 Thanks To OpenAI Tie-Up", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPdm03ODZYLWk4RkZDdjlvUV9PNnVjWWYydXFqeEFlQXJWWldJakROV3cxYWs1MjlJbFJteVB0LTJlRldSa2VrX0oyNDBFSDc5Yk80d0JqNmh6NWVsUE54NHhPMmJ4ZXZ2QVhZZDRDcXlsb3VfcFA5eEdSa3pfaHp5LVBiVnMwMmRyZUFmYVdNMVlZSmt0M1A1RHFvRFFvU3QycFd1VndOblVxM0hzUTB3VmZuVWQ0N1Nf?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-16T20:40:33+00:00", "published_display": "16 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (CPSE:NOVO B) Stock Fair Value Edges Higher As Analysts Rework Growth Assumptions", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPRS01WFZyWkZFWHV5MEFmcU44STIzVVEwX1p6VlpLd203OWhGSXFuQmFZbUJjVXg4d2R0Q0cxTzBsdktqQ25ub3B5YmxqeDZPM1ZLUjJnVG5CZmhyOGoya3BLMjUyX1ZKNFBIZWxoZ2JEM211ekZELU5vbml5TEh3SnNKbUNjQXc0aXpQU2pB?oc=5", "source_name": "Market source", "published_at": "2026-07-15T23:15:42+00:00", "published_display": "15 Jul 2026 23:15", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Novo Nordisk (NVO) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxNVl9TQ2lEQkt1elY4R2ZOZ0ViN1BEaU5TMWdVV0QzQmk3d2h2c1dKTkt4S1hBOTZHOUU4amJLU0Z3QnRFUm9FRDhiaGh2WnNuNVNpdHRmRE81NHFjSUhnWnpFYVdxc0lHUUN0NzVGUGJYcFdUNzVic0xOeWVBamFQQ2RKcw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-15T15:37:00+00:00", "published_display": "15 Jul 2026 15:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Two Overhyped GLP-1 Stocks Present Buying Opportunities on Dips, with Novo Nordisk and Kailera Therapeutics Each Offering Unique Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxQRHZWS3d6MXd5QzQ4N3hKc09JMmVDZGlFdW5ScGdQWkM0djdkYjNiNWRPcHhXLUJnVG1rZ25ORTVudGx5WG81X1JzS2s3ZXRMbU9sNk9sdHItdjBpaFBLV1pQSjBEdV9iTUhkTkZwQlRiTTdMUXJoQl9KRDRjcjRjY3FIWWxzZnpicjdaSUdLYzM4RTRUbmwxbmo0aW1rLUdYWWZ6dHhLWGVYWDJ5UUhHSm91U1g4akozbVAxTER3eUJnZk51bkhMbDQ4NDZUeGRXcU42MURTN21IMWFyVDlSZXNaTFRoNWowRFBsNTFzQ2Y0cjNBQVYxelRzRnFDREFw?oc=5", "source_name": "NAI500", "published_at": "2026-07-15T06:28:06+00:00", "published_display": "15 Jul 2026 06:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[6-K] NOVO NORDISK A S Current Report (Foreign Issuer) | NVO SEC Filing - Form 6-K", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOUlJjZ1MtZnZxbmUyVTQ5ZnEwOTdsbmtYaEhxdEt2Q2VfVUs2bC0ySzhsa2c3bjdPWE1RX1RLNmJSS3YzYTFPc01LaHRsNGJVWTFrc1ZCQzFRb05xZ25vSXJvQmJOd25aRGxHLTFSVWdia3NsZnhDci0xem5NdzlXakFOOGVRendoWXNCT19MRmZWQS1scDRReERvbC1peDJCMnkxaE12S04xeTRJdEo4aw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-13T13:25:01+00:00", "published_display": "13 Jul 2026 13:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NYSE: NVO) details progress on DKK 15B share repurchase", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPSHY1V1BYS2tucklfQlZMR3Y1WDcxWWs5NmFTZDd5OV9rR3dKTHNOZE9Xb1d4SERPMUtoQ3djV0dJMHdNNkFqcGZLbUVLS3A5WTFGY2J4a0gwdWVKLXVBY3h0Vkl5bWFuelIxOGdnUWdmblBtelBmamwyZkt6OEdad0tteVV2RXQ3WE9sOVVkVzhhMVpxellKOWMwRGxMdFktVlh2enNFejRxSW1ERVVyaQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Stock Price Is Only Beginning To Catch Up With Business Fundamentals (NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOTC1OcXdVeFd4d3ZLVTJjaTZSZnpqbVF5dGo5VThBcE8weXBoMjNOVEpJa2t2RWhLOHQxZnRIVzhTZllySGNuWTJ6LXlBWVBEamFkLURtQXZqN3BSTUVmck5JbGthcktMWTRDYTNDMThwc3liMmlyWXB3eGJqbmlEU2JLQlVYZ1pRUWZnTDJabXppMks5eTdKR3RaZlk0c3BQbzlka2F5OHBYeW1EY0tsUnA0TWNlTjdkZWxPcTRtOFBzY3NP?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NVO) Stock May Be 48% Undervalued On Medicare GLP 1 Coverage", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQeGdsX3ZZQlZOenVVZGhidEpheEp6NmxLN0pIYlNrODNNQmlfWVc5SEt4dzBEMVJyLXJGZFVJb08xOVZEOFRubU5abkZKb0dkQlZpaFhjLWxaMENfeElBMEstZDBudlA2dmZGMmFQUVhCU0s1VnhLd1VvWXN6VnFGV1VUaTNKVHpTSDRIYUhsTzFhWlFSUFE?oc=5", "source_name": "Market source", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NVO) Upgraded to Buy at Nordea. Here is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPMXByUFoxYkg4OUZtNDktTG9oNHZObnM3Ti1MV1NCN25BTjB4d0JpM242Zy1Sb0dXMGNMZENxeG11WEVkaWJibHNnSGJvTm1UWWdJV3RoeHpVWXlMVG0xZXBiTUNIckhtQnZEMU5sY2NZOWt0RExVTUprV0NUZjFseVFWSG1VSm9QNUtuZVk2cTVLQjFj?oc=5", "source_name": "Market source", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NYSE: NVO) Stock Price Gains Ground As UK Approves Wegovy Pill For Weight Management", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQTS1EYUwzZ0luQVBTaGl2X19MSUktc2hVdUZ3T2hKV3dOeVRnclpRemIyeWt5NTVjVFB3cDItNExybkF3ZEp5RlhNLWtlREVGRFRsM215NlJxZ0tTTGswR1FWLTFZY0dmYmhyWlo0cGVpUzZFLTBKSlUwRUhDeXVyWTBzQy1neGRudXJyVXozMmZDTHFsZ3BJdFVBTUZEaDFJZ2JoN0JsLU9FQUQ4ZS1adURoenVDeWZIb1dBV0RPRUkwaFlHSmZzbmFRaUxZYUI2VEJUY2x6dThvYmFG?oc=5", "source_name": "foreignpolicyjournal.com", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQdjlPQkRyWnNxTnE0bFotdTlOdDAxMnBFM2UxTFlEX0JncExIWHFybHVFbHdHOVU3cUpVaUFvWEI5YmYyUVBlZ2hTdXoxYkFsU1BMN3BIelUxN3U3T3lWUV9MWHQtSms4ZlFqNndrQjgzbkZUcE9sSmVVWktMWExGT3VzTVBMMFRITEdxT010UjJ2TVYwWGR1bUUwZFI?oc=5", "source_name": "Market source", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NYSE: NVO) repurchases 20,959,179 shares in 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQWWtiQm1XbXRMdkY2WjFvNXh3d2hqRTN6Q3VwckRlOGFxaGN6LTBEcDc0ZTRuN1BSUE1vMGctQ1pYRWRNb3JpZTM5a3FtWGVwQnF4U1MzaVI5YVBBeGhQTXVMMUV4WWJsYzJkMUYxRkNhRDc3VG5Xa0JJaE1NLUFPVU0zRHU5QjRuX1AybTl2UlFKc2FWVnFVcTJPRENfUTYtZ2V2ZER2c2ZhTkx2N01HLQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here is why Novo Nordisk A/S (NVO) is among the Best Longevity and Anti-Aging Stocks to Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNcTQxVmFLZGVZejhyX2pIRFJONzFBUlhRRUtnZmFNZERZTkFZUmtLeml0R0dnVENVdTd3SF9xSlVvdWhQQnFPSWxRM1F4dklFemdkckFfZy1aTTV6WUR6cUc2enhEbEJxNnM3cGVKZGQ1ZFFOdVVLNlR4SVN0NXRiYk0yQnhGcXZFOERZa2VSUjE?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk A/S - share repurchase programme", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQc0VDVmplRzFoLXlUaF9GNEtxOXRWQzdkakgzeEltbGdWZ1Q3NVJxTzlJZzF4RmpfMHZFTXFET2ZXM3pIX0Q5QTNRUG5tRVBFT2lJVFUyaUZhUkpqRDBUeldkcjRLcTRuRThkQUFyMkxyd0wwTXNjdFlkQUN3clRJQzVFNzhQaGUxd2tPWXdfZHV6TWUxYmMtVUphcjNqQUx4RktSU1psMjRUQW1MaVRtbVlJazlVZw?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: The Danish Empire Strikes Back (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOeDJWeUp1NV80TXBNZzYwZk5rQU9VUGJOLVAzc29zMXM2NjhFVlpoVURHRU1fb3Q2a19vc1JRakR5SGF3cW5mdWh2WGpYWDI5ZFRDQlB4WXhmZUFzTFdjTEhZV2FfYm01elhlR1MwQmJ0a0tFRXVHT1VuSjZQZnBtb04tYm03UDNuZUhFUnp6Zw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NVO) repurchases 19.9M B shares under 2026 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQYU1tYTh3QU1PcmNqSGtqVzNYNXljVGh5VUtpeXJsb3ZZZXFJZmZRcVlrTG1TQkZqQnFKU0RmaG4wY1o0SkpCcVhrT1BJOXY2Zk5TRDU4dnVJelBOUy1jUmZpLTExc3UzS3BYV3NBUnZlX1dDbktXeHVNRGtjOWpXWlN4R1B2TWtQM28zRmhha2F2V0NVYXQxeGprSHo5Ync2Y3d0b2JuWXJxNVZGR1QyQw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Deeply Undervalued With A Return To Growth In 2027 (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPVkRGbUFDYWctaUZseFNrSmtscEJJemliXzRfMVFOSEN3NVZtNGFVWTJOYXZ5S1NqbllELUowLXExUE9rdGp0NlViTGFCV0VNaVBvd0JQSExYYkNZQ3c5X3ViSlVheTNhV2c0UF9YcVQzTFgyV0hiR282VXBncFRDQ2hhMVlvMlI1RjdJVVNEbUpMb0tOclhnMFJkYm1zNGxsTEJ2aUh5OA?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's What I Think Is Really Going on With Novo Nordisk Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNUTlOdWhZNHZJblBzZlZKakV6TnBiMFVyUW0weHo3emZWaHN6TURLYU1qMm9VOWtXRzVkNXJFX2ZXWjdMRHdMRnZTdFF0VkNHWS1CeW5WQWpfV0p1S3RUa0VNYmY3S2Z5UlhwMnFGN1VHMElJZV93M09WQk00YUNBZWd6LUxwSGt0UnFfWWg1UWxwVkVHYkJrUg?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNZ1dXNXVfWms2NTRIVTBleGRZVzFYRHM3TE1tM3B6TE1uRGo5dE1rOWNQUTVsQURqV1ZFNmNoUTNjbXZtaHVhVU4yYTEtcDlrWUxra3R5TVZ4SDRHOXkyRWs0b1hLcnE0d2lTSzlaWnl4Uk5JRVk1ZnJiSGVubENSQTdJMjNpeE9kblkyQmw1dUFweDY1RjQtMUpwc2gzX3M?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk - Enough Is Enough: 5 Reasons It's Time To Sell (Rating Downgrade)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPMUt3eEN2aXcwbk1nUDBVQ015VmwzMXhfX3hfREV1OEdieHczOGRTNUo0UVBmX3NpMTZRZUktR1d0bm83YWJ4emxpQmNnNXVJZ05GRXVscFhqMDFtYkJCSEYtTkExa29FQ05ORDdiYkVSbGs5SzZrbUVEdjNMMUMxT25EbXYzZDRFb3l6d2FmTlU0UTVHVXU4SkJZbjB1RDBuWm1mSXZGdU1mQUxnTHNsbVJwX08?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPaTdmamc4QU9IekYyT2hOdlVOdlowVjFnZE84b29mN3RuNXFUMURRaUEwTUkzMEwxVllJT3NzdHo3ZjNoYmJmZk41QUpkSTRacmdCd2ZpSVkxdE1icFVXUVVOVUExblRobUpuT2FUSV8td3dCUS00dm5NYU5LYmFTTEdLT0lhQm9naEczT2lySU9GSS1ZUFpEZnNCemFVUk9lejMxR2RBVFNScFBRamlpbEpjQU1iX0RmVjlJVXZJR0k2T2dGZkJWVWItaDY4czE3YkdTT1Fab05tUQ?oc=5", "source_name": "Reuters", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Trial Flop Ripples Through Denmark\u2019s Stock Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNbHVoelhYZ2d1UF9CT2ppcjJWaTNTYl94Y2dYZ3p0YXhTdGRMT0ZncHFNTjBrczJtbUJvRktaTFRZS0pVQXNVTmFZY0VFX1VlOWpXeDJQWGxXWnhiQWxZRTVqZWtHcV9MQWJ4cWIwZFNhTlh6YXFjRFQya1V0OGhxcE9zLVVwZ1BaN09nZ1ZJa1RNdEZZMHpMb1RZa3VDVTFrNGJGTGtSdi1hMF95OWhLYXA2bw?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk sinks 16% after weight loss drug fails to match Eli Lilly's in trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxOenhCczZXZ2N1MnVxZk4wZENfbjh4LXFBYVc3RVc5VmF4dVFNa0s5Y0V0NHhTTWF6TEZWUmJtQTF3U1VTaEUzTFVkYkx3VWt5R0JfaEF3WnNkdnN1M2VVT2VTeExBNk1rNzJQQzJoVlp0eFh0V0IzYU1lUVdhX1c2Vm9hbThiTGRyblJiYVU4ajVHRzjSAZgBQVVfeXFMTk1ObWFJcUdYWklUTnVyak9KTzB0dWd4R2hOdGQzY3V5dVF1YzRmaWpteFFVeWlCVnlOMDZ3MlVLUF9JTGhyUXZSSTJHa3dNN1I5VjZJd05EbWlYbm8yQzdob2dpTVYwUms1VUtldFdQSi0zVU4tSXg2dGNoU29sN3R2TFNTdmdTY29wcTRpUHhtdThHZWQxOUY?oc=5", "source_name": "CNBC", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk shares rebound as FDA targets illegal drug copies", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxQc1VOTTI1MlRtU0Jxc0Q0MF8xQkUyazQtLXBXUzhJRWx2MlFqMmFtWXBZRTc4WURUeFcwLTF5Uy10R1luaUZINGFhNWlRRXcxUGozWHp4SU5DLWdvRzBCY3R4bWhuWnFuNXNQRkFsZVlld0tqTGlOejV3OTJ1bUpMemlwV2FJMzdkRG1PM0Mxc0IwV2o3WGlQdlRsUldpV2NqdUx1TmhPRXFMMXhNbWZmZ2Y0c2ZtLWVySjlzZU1yY3U4N1hXNUYzM0JjYnJzLUJ1?oc=5", "source_name": "Reuters", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Novo Nordisk stock trades near record levels as obesity and diabetes momentum supports earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOdXFiNllNOG5XUC1MNVZmUXhuSGZINHo1U0dWeUhXQU5Cay16LUZ3aWEtRUV3SUpnaFZuR0VoREpleGpHVEJyT2pWWFZvZEg2N1hJLWNGWkFoazR3cUVsclo0anVuTHJhdU9nRnpkRy1lbVlGOC04dlFxWXRBVVh4dnJKVEhsZ0s0djBRMzRCSGlKZm50UGE4STFwT2hwLWpObFRwTWlVSVN3NTN5Ymg5YW9obzd3V29XbWVMbkhJYjhLMnNIcmc?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-18T05:55:14+00:00", "published_display": "18 Jul 2026 05:55", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: EU Approval of Wegovy Pill Expands Opportunity, but Cash Pay Raises Systematic Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQaDNxLTU4ZE54al81a19uZ2p1MnBnb2JkU1VuQnotRnFRNGo0WTYxVnJyTGQ0b09zbWpIck85dUZSX0NncnRYVmMtdjE0R0N2QWg5c3RrYWVKWkQ2cTVwU1VLVTBLLVZTQXF3Tkh4YlYxSHNpZkRRMjZ2dlpndVpHaldfSjlrUEFTX0hqdE1HZUhKRzZSVzN6aGRLX1phV1RpbHpOWkoxT0d3ejlBUmdyS29TY3VmWjBVanBNREZPcTQ?oc=5", "source_name": "Morningstar", "published_at": "2026-07-17T17:59:32+00:00", "published_display": "17 Jul 2026 17:59", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: The Oral Wegovy Promise (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQb01MdlVpaEx4MkJMVDBLd3VLZUFiNjJYeGN2SEgyY3cxWXBvajhpQS1lVXdEYlplV3ZIWllOa2RrZjczdEx3VVlRNXdrZU1yOEpMMUdTa2pUaThhc1ZJc2loT3hNZXZoYThfdXFiM3V5Y0RtcUhMay1YMHBlOTFyM1ZxUQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-17T15:12:03+00:00", "published_display": "17 Jul 2026 15:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NVO) Ascends While Market Falls: Some Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSjJYdTRoRXFoZ1FMUjNQMTZuNHdZNHBWcGxheEtzMjVwbnRCbHJoQ1VrR3poU0JpcWVuNkRDVm9vMVZIZF9LenowZ1R0bHpuOVphZlBDOFpzT3Ixa1MyMmNTaWV5azRzVWZZS2kyS1ppbHRHMFhuOUlmaWctSzJveWlkVkRKbWdXY1dBc0Q3Nm0xUWJxSmhSU01BYw?oc=5", "source_name": "Market source", "published_at": "2026-07-16T21:45:02+00:00", "published_display": "16 Jul 2026 21:45", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Stock Up Over 2% Premarket Today \u2014 Thanks To OpenAI Tie-Up", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPdm03ODZYLWk4RkZDdjlvUV9PNnVjWWYydXFqeEFlQXJWWldJakROV3cxYWs1MjlJbFJteVB0LTJlRldSa2VrX0oyNDBFSDc5Yk80d0JqNmh6NWVsUE54NHhPMmJ4ZXZ2QVhZZDRDcXlsb3VfcFA5eEdSa3pfaHp5LVBiVnMwMmRyZUFmYVdNMVlZSmt0M1A1RHFvRFFvU3QycFd1VndOblVxM0hzUTB3VmZuVWQ0N1Nf?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-16T20:40:33+00:00", "published_display": "16 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (CPSE:NOVO B) Stock Fair Value Edges Higher As Analysts Rework Growth Assumptions", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPRS01WFZyWkZFWHV5MEFmcU44STIzVVEwX1p6VlpLd203OWhGSXFuQmFZbUJjVXg4d2R0Q0cxTzBsdktqQ25ub3B5YmxqeDZPM1ZLUjJnVG5CZmhyOGoya3BLMjUyX1ZKNFBIZWxoZ2JEM211ekZELU5vbml5TEh3SnNKbUNjQXc0aXpQU2pB?oc=5", "source_name": "Market source", "published_at": "2026-07-15T23:15:42+00:00", "published_display": "15 Jul 2026 23:15", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Novo Nordisk (NVO) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxNVl9TQ2lEQkt1elY4R2ZOZ0ViN1BEaU5TMWdVV0QzQmk3d2h2c1dKTkt4S1hBOTZHOUU4amJLU0Z3QnRFUm9FRDhiaGh2WnNuNVNpdHRmRE81NHFjSUhnWnpFYVdxc0lHUUN0NzVGUGJYcFdUNzVic0xOeWVBamFQQ2RKcw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-15T15:37:00+00:00", "published_display": "15 Jul 2026 15:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Two Overhyped GLP-1 Stocks Present Buying Opportunities on Dips, with Novo Nordisk and Kailera Therapeutics Each Offering Unique Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxQRHZWS3d6MXd5QzQ4N3hKc09JMmVDZGlFdW5ScGdQWkM0djdkYjNiNWRPcHhXLUJnVG1rZ25ORTVudGx5WG81X1JzS2s3ZXRMbU9sNk9sdHItdjBpaFBLV1pQSjBEdV9iTUhkTkZwQlRiTTdMUXJoQl9KRDRjcjRjY3FIWWxzZnpicjdaSUdLYzM4RTRUbmwxbmo0aW1rLUdYWWZ6dHhLWGVYWDJ5UUhHSm91U1g4akozbVAxTER3eUJnZk51bkhMbDQ4NDZUeGRXcU42MURTN21IMWFyVDlSZXNaTFRoNWowRFBsNTFzQ2Y0cjNBQVYxelRzRnFDREFw?oc=5", "source_name": "NAI500", "published_at": "2026-07-15T06:28:06+00:00", "published_display": "15 Jul 2026 06:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[6-K] NOVO NORDISK A S Current Report (Foreign Issuer) | NVO SEC Filing - Form 6-K", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOUlJjZ1MtZnZxbmUyVTQ5ZnEwOTdsbmtYaEhxdEt2Q2VfVUs2bC0ySzhsa2c3bjdPWE1RX1RLNmJSS3YzYTFPc01LaHRsNGJVWTFrc1ZCQzFRb05xZ25vSXJvQmJOd25aRGxHLTFSVWdia3NsZnhDci0xem5NdzlXakFOOGVRendoWXNCT19MRmZWQS1scDRReERvbC1peDJCMnkxaE12S04xeTRJdEo4aw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-13T13:25:01+00:00", "published_display": "13 Jul 2026 13:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NYSE: NVO) details progress on DKK 15B share repurchase", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPSHY1V1BYS2tucklfQlZMR3Y1WDcxWWs5NmFTZDd5OV9rR3dKTHNOZE9Xb1d4SERPMUtoQ3djV0dJMHdNNkFqcGZLbUVLS3A5WTFGY2J4a0gwdWVKLXVBY3h0Vkl5bWFuelIxOGdnUWdmblBtelBmamwyZkt6OEdad0tteVV2RXQ3WE9sOVVkVzhhMVpxellKOWMwRGxMdFktVlh2enNFejRxSW1ERVVyaQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Stock Price Is Only Beginning To Catch Up With Business Fundamentals (NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOTC1OcXdVeFd4d3ZLVTJjaTZSZnpqbVF5dGo5VThBcE8weXBoMjNOVEpJa2t2RWhLOHQxZnRIVzhTZllySGNuWTJ6LXlBWVBEamFkLURtQXZqN3BSTUVmck5JbGthcktMWTRDYTNDMThwc3liMmlyWXB3eGJqbmlEU2JLQlVYZ1pRUWZnTDJabXppMks5eTdKR3RaZlk0c3BQbzlka2F5OHBYeW1EY0tsUnA0TWNlTjdkZWxPcTRtOFBzY3NP?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NVO) Stock May Be 48% Undervalued On Medicare GLP 1 Coverage", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQeGdsX3ZZQlZOenVVZGhidEpheEp6NmxLN0pIYlNrODNNQmlfWVc5SEt4dzBEMVJyLXJGZFVJb08xOVZEOFRubU5abkZKb0dkQlZpaFhjLWxaMENfeElBMEstZDBudlA2dmZGMmFQUVhCU0s1VnhLd1VvWXN6VnFGV1VUaTNKVHpTSDRIYUhsTzFhWlFSUFE?oc=5", "source_name": "Market source", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NVO) Upgraded to Buy at Nordea. Here is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPMXByUFoxYkg4OUZtNDktTG9oNHZObnM3Ti1MV1NCN25BTjB4d0JpM242Zy1Sb0dXMGNMZENxeG11WEVkaWJibHNnSGJvTm1UWWdJV3RoeHpVWXlMVG0xZXBiTUNIckhtQnZEMU5sY2NZOWt0RExVTUprV0NUZjFseVFWSG1VSm9QNUtuZVk2cTVLQjFj?oc=5", "source_name": "Market source", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NYSE: NVO) Stock Price Gains Ground As UK Approves Wegovy Pill For Weight Management", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQTS1EYUwzZ0luQVBTaGl2X19MSUktc2hVdUZ3T2hKV3dOeVRnclpRemIyeWt5NTVjVFB3cDItNExybkF3ZEp5RlhNLWtlREVGRFRsM215NlJxZ0tTTGswR1FWLTFZY0dmYmhyWlo0cGVpUzZFLTBKSlUwRUhDeXVyWTBzQy1neGRudXJyVXozMmZDTHFsZ3BJdFVBTUZEaDFJZ2JoN0JsLU9FQUQ4ZS1adURoenVDeWZIb1dBV0RPRUkwaFlHSmZzbmFRaUxZYUI2VEJUY2x6dThvYmFG?oc=5", "source_name": "foreignpolicyjournal.com", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQdjlPQkRyWnNxTnE0bFotdTlOdDAxMnBFM2UxTFlEX0JncExIWHFybHVFbHdHOVU3cUpVaUFvWEI5YmYyUVBlZ2hTdXoxYkFsU1BMN3BIelUxN3U3T3lWUV9MWHQtSms4ZlFqNndrQjgzbkZUcE9sSmVVWktMWExGT3VzTVBMMFRITEdxT010UjJ2TVYwWGR1bUUwZFI?oc=5", "source_name": "Market source", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NYSE: NVO) repurchases 20,959,179 shares in 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQWWtiQm1XbXRMdkY2WjFvNXh3d2hqRTN6Q3VwckRlOGFxaGN6LTBEcDc0ZTRuN1BSUE1vMGctQ1pYRWRNb3JpZTM5a3FtWGVwQnF4U1MzaVI5YVBBeGhQTXVMMUV4WWJsYzJkMUYxRkNhRDc3VG5Xa0JJaE1NLUFPVU0zRHU5QjRuX1AybTl2UlFKc2FWVnFVcTJPRENfUTYtZ2V2ZER2c2ZhTkx2N01HLQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here is why Novo Nordisk A/S (NVO) is among the Best Longevity and Anti-Aging Stocks to Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNcTQxVmFLZGVZejhyX2pIRFJONzFBUlhRRUtnZmFNZERZTkFZUmtLeml0R0dnVENVdTd3SF9xSlVvdWhQQnFPSWxRM1F4dklFemdkckFfZy1aTTV6WUR6cUc2enhEbEJxNnM3cGVKZGQ1ZFFOdVVLNlR4SVN0NXRiYk0yQnhGcXZFOERZa2VSUjE?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk A/S - share repurchase programme", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQc0VDVmplRzFoLXlUaF9GNEtxOXRWQzdkakgzeEltbGdWZ1Q3NVJxTzlJZzF4RmpfMHZFTXFET2ZXM3pIX0Q5QTNRUG5tRVBFT2lJVFUyaUZhUkpqRDBUeldkcjRLcTRuRThkQUFyMkxyd0wwTXNjdFlkQUN3clRJQzVFNzhQaGUxd2tPWXdfZHV6TWUxYmMtVUphcjNqQUx4RktSU1psMjRUQW1MaVRtbVlJazlVZw?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: The Danish Empire Strikes Back (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOeDJWeUp1NV80TXBNZzYwZk5rQU9VUGJOLVAzc29zMXM2NjhFVlpoVURHRU1fb3Q2a19vc1JRakR5SGF3cW5mdWh2WGpYWDI5ZFRDQlB4WXhmZUFzTFdjTEhZV2FfYm01elhlR1MwQmJ0a0tFRXVHT1VuSjZQZnBtb04tYm03UDNuZUhFUnp6Zw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NVO) repurchases 19.9M B shares under 2026 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQYU1tYTh3QU1PcmNqSGtqVzNYNXljVGh5VUtpeXJsb3ZZZXFJZmZRcVlrTG1TQkZqQnFKU0RmaG4wY1o0SkpCcVhrT1BJOXY2Zk5TRDU4dnVJelBOUy1jUmZpLTExc3UzS3BYV3NBUnZlX1dDbktXeHVNRGtjOWpXWlN4R1B2TWtQM28zRmhha2F2V0NVYXQxeGprSHo5Ync2Y3d0b2JuWXJxNVZGR1QyQw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Deeply Undervalued With A Return To Growth In 2027 (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPVkRGbUFDYWctaUZseFNrSmtscEJJemliXzRfMVFOSEN3NVZtNGFVWTJOYXZ5S1NqbllELUowLXExUE9rdGp0NlViTGFCV0VNaVBvd0JQSExYYkNZQ3c5X3ViSlVheTNhV2c0UF9YcVQzTFgyV0hiR282VXBncFRDQ2hhMVlvMlI1RjdJVVNEbUpMb0tOclhnMFJkYm1zNGxsTEJ2aUh5OA?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's What I Think Is Really Going on With Novo Nordisk Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNUTlOdWhZNHZJblBzZlZKakV6TnBiMFVyUW0weHo3emZWaHN6TURLYU1qMm9VOWtXRzVkNXJFX2ZXWjdMRHdMRnZTdFF0VkNHWS1CeW5WQWpfV0p1S3RUa0VNYmY3S2Z5UlhwMnFGN1VHMElJZV93M09WQk00YUNBZWd6LUxwSGt0UnFfWWg1UWxwVkVHYkJrUg?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNZ1dXNXVfWms2NTRIVTBleGRZVzFYRHM3TE1tM3B6TE1uRGo5dE1rOWNQUTVsQURqV1ZFNmNoUTNjbXZtaHVhVU4yYTEtcDlrWUxra3R5TVZ4SDRHOXkyRWs0b1hLcnE0d2lTSzlaWnl4Uk5JRVk1ZnJiSGVubENSQTdJMjNpeE9kblkyQmw1dUFweDY1RjQtMUpwc2gzX3M?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk - Enough Is Enough: 5 Reasons It's Time To Sell (Rating Downgrade)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPMUt3eEN2aXcwbk1nUDBVQ015VmwzMXhfX3hfREV1OEdieHczOGRTNUo0UVBmX3NpMTZRZUktR1d0bm83YWJ4emxpQmNnNXVJZ05GRXVscFhqMDFtYkJCSEYtTkExa29FQ05ORDdiYkVSbGs5SzZrbUVEdjNMMUMxT25EbXYzZDRFb3l6d2FmTlU0UTVHVXU4SkJZbjB1RDBuWm1mSXZGdU1mQUxnTHNsbVJwX08?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPaTdmamc4QU9IekYyT2hOdlVOdlowVjFnZE84b29mN3RuNXFUMURRaUEwTUkzMEwxVllJT3NzdHo3ZjNoYmJmZk41QUpkSTRacmdCd2ZpSVkxdE1icFVXUVVOVUExblRobUpuT2FUSV8td3dCUS00dm5NYU5LYmFTTEdLT0lhQm9naEczT2lySU9GSS1ZUFpEZnNCemFVUk9lejMxR2RBVFNScFBRamlpbEpjQU1iX0RmVjlJVXZJR0k2T2dGZkJWVWItaDY4czE3YkdTT1Fab05tUQ?oc=5", "source_name": "Reuters", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Trial Flop Ripples Through Denmark\u2019s Stock Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNbHVoelhYZ2d1UF9CT2ppcjJWaTNTYl94Y2dYZ3p0YXhTdGRMT0ZncHFNTjBrczJtbUJvRktaTFRZS0pVQXNVTmFZY0VFX1VlOWpXeDJQWGxXWnhiQWxZRTVqZWtHcV9MQWJ4cWIwZFNhTlh6YXFjRFQya1V0OGhxcE9zLVVwZ1BaN09nZ1ZJa1RNdEZZMHpMb1RZa3VDVTFrNGJGTGtSdi1hMF95OWhLYXA2bw?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk sinks 16% after weight loss drug fails to match Eli Lilly's in trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxOenhCczZXZ2N1MnVxZk4wZENfbjh4LXFBYVc3RVc5VmF4dVFNa0s5Y0V0NHhTTWF6TEZWUmJtQTF3U1VTaEUzTFVkYkx3VWt5R0JfaEF3WnNkdnN1M2VVT2VTeExBNk1rNzJQQzJoVlp0eFh0V0IzYU1lUVdhX1c2Vm9hbThiTGRyblJiYVU4ajVHRzjSAZgBQVVfeXFMTk1ObWFJcUdYWklUTnVyak9KTzB0dWd4R2hOdGQzY3V5dVF1YzRmaWpteFFVeWlCVnlOMDZ3MlVLUF9JTGhyUXZSSTJHa3dNN1I5VjZJd05EbWlYbm8yQzdob2dpTVYwUms1VUtldFdQSi0zVU4tSXg2dGNoU29sN3R2TFNTdmdTY29wcTRpUHhtdThHZWQxOUY?oc=5", "source_name": "CNBC", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk shares rebound as FDA targets illegal drug copies", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxQc1VOTTI1MlRtU0Jxc0Q0MF8xQkUyazQtLXBXUzhJRWx2MlFqMmFtWXBZRTc4WURUeFcwLTF5Uy10R1luaUZINGFhNWlRRXcxUGozWHp4SU5DLWdvRzBCY3R4bWhuWnFuNXNQRkFsZVlld0tqTGlOejV3OTJ1bUpMemlwV2FJMzdkRG1PM0Mxc0IwV2o3WGlQdlRsUldpV2NqdUx1TmhPRXFMMXhNbWZmZ2Y0c2ZtLWVySjlzZU1yY3U4N1hXNUYzM0JjYnJzLUJ1?oc=5", "source_name": "Reuters", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 86, "total_relevant": 28, "sentiment_summary": {"positive": 7, "negative": 3, "neutral": 18, "score": 53, "total": 28, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 88, "events": [{"event": "general", "label": "Market update", "weight": 14.9, "count": 22}, {"event": "analyst", "label": "Analyst action", "weight": 1.45, "count": 2}, {"event": "capital_return", "label": "Capital return", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.9, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 7, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 329.9, "latest_week": "2026-07-17", "one_week_move": 2.4, "four_week_move": 12.6, "twelve_week_move": 26.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.016595, "market_dynamics_buy_signal": false, "relative_strength": -1.234026, "fair_value_gap": -39.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 48.5456, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.4% over one week, +12.6% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 64, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 7}, {"label": "Seeking Alpha", "count": 5}, {"label": "Stock Titan", "count": 4}, {"label": "Reuters", "count": 2}, {"label": "ad-hoc-news.de", "count": 1}, {"label": "Morningstar", "count": 1}, {"label": "Stocktwits", "count": 1}, {"label": "Quiver Quantitative", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 28}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 22}, {"label": "Capital return", "count": 2}, {"label": "Analyst action", "count": 2}, {"label": "Earnings", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "88/100 classification confidence."}, {"label": "Company focus", "value": "28", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "10", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.4% over one week, +12.6% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Novo Nordisk stock trades near record levels as obesity and diabetes momentum supports earnings"}], "updated_at": "2026-07-18T16:03:47.078370+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}